Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linqu H. pylori eradication trial for gastric cancer prevention
ChiCTR-TRC-10000979Phase 4Completed
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jan 2010
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of omeprazole, bismuth subcitrate, metronidazole and tetracycline in Helicobacter pylori infection (2 arms), sponsored by Peking University Cancer Hospital & Institute. Primary endpoint: Incidence rate of gastric cancer. Started Jan 2010; status: completed.
02
Drugs
omeprazolebismuth subcitratemetronidazoletetracycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR-TRC-10000979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000979.